Journal Logo

Most Popular Articles

Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial

Miyaoka, Tsuyoshi; Kanayama, Misako; Wake, Rei; More

Clinical Neuropharmacology. 41(5):151-155, September/October 2018.

Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity

Pérez-Arredondo, Adán; Cázares-Ramírez, Eduardo; Carrillo-Mora, Paul; More

Clinical Neuropharmacology. 39(6):311-319, November/December 2016.

Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study

Aragona, Massimiliano; Onesti, Emanuela; Tomassini, Valentina; More

Clinical Neuropharmacology. 32(1):41-47, January-February 2009.

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

Kitta, Takeya; Yabe, Ichiro; Kanno, Yukiko; More

Clinical Neuropharmacology. 41(3):98-102, May/June 2018.

Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD): An 11-Week Randomized Comparison Trial Against Pramipexole and Ropinirole

Eggert, Karla; Öhlwein, Christian; Kassubek, Jan; More

Clinical Neuropharmacology. 37(4):116-122, July/August 2014.

Show: